Avoro Capital Advisors LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.18 Billion
- Q1 2025
A detailed history of Avoro Capital Advisors LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 11,111,111 shares of ARWR stock, worth $168 Million. This represents 2.29% of its overall portfolio holdings.
Number of Shares
11,111,111
Previous 11,111,111
-0.0%
Holding current value
$168 Million
Previous $209 Million
32.23%
% of portfolio
2.29%
Previous 3.04%
Shares
9 transactions
Others Institutions Holding ARWR
# of Institutions
300Shares Held
98MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$237 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$200 Million0.0% of portfolio
-
State Street Corp Boston, MA7MShares$106 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$79.2 Million1.32% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL4.79MShares$72.4 Million0.02% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.6B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...